Table 3. Clinical Characteristics and Pre-PAS TMS Parameters of Patients Who Participated in the Follow-Up Assessment (T2).
| Remitters (n=8) | Non-remitters (n=8) | t/χ2 | p | |
|---|---|---|---|---|
| Demographic parameters | ||||
| Sex (m/f) | 6/2 | 4/4 | χ2=1.1 | 0.608 |
| Age (years) | 39.0±10.8 | 44.5±11.9 | 1.0 | 0.350 |
| Clinical characteristics | ||||
| BDI-II | 6.6±3.7 | 29.4±11.7 | 5.2 | <0.001 |
| PSQ | 37.7±16.2 | 70.6±16.2 | 4.1 | 0.001 |
| Pre-PAS TMS parameters | ||||
| MEP amplitudes (mV) | 0.8±0.2 | 0.9±0.3 | 0.8 | 0.418 |
| Resting motor threshold (% MSO) | 35.8±4.0 | 39.3±6.3 | 1.3 | 0.202 |
| Stimulation intensity TMS (% MSO) | 46.4±6.7 | 46.4±9.1 | <0.01 | >0.999 |
Abbreviations: BDI-II, Beck Depression Inventory-Second Edition; MEP, motor-evoked potential; MSO, maximum stimulator output; mV, millivolt; PSQ, Perceived Stress Questionnaire; TMS, transcranial magnetic stimulation.
Data represent means±standard deviations. Student's t-tests for independent samples were used, where applicable. Significant results are given in bold.